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Results: During and after procedures we observed in 28% patients 
hypoxemia, in 23 % hemorrhage 250 cm3 and more, in 10% arytmias, 
in 5% patients we observed hypertension and in 2% patients developed 
after procedure respiratory failure and both patients were 24 hours 
on invasive ventilation. Two patients died due complications after 
procedure. Any complications we observed in 40% of all procedures. 
The procedure leads to improvement of symptoms in 80% patients. 
The difference in number of complications in patients with ASA III and 
with ASA IV was not statistically signiﬁcant (p=0.009).
Conclusions: Endobronchial treatment (electrosurgary and laser 
brochoscopy) leads to improvement of symptoms in 80% patients. 
This treatment procedure in general anesthesia with jet ventilation is 
therapeutic procedure with acceptable rate of complications in patients 
with endobronchial growth of malignancies and in patients with ASA 
classiﬁcation III and IV.
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Background: Bronchoscopy is usually performed under topical anes-
thesia with or without sedation to promote patient comfort and the ideal 
conditions for the physician to perform the examination. The objective 
of the study was to establish which anesthetic procedure used during 
ﬂexible bronchoscopy for lung cancer diagnostic has the lowest index 
of complications. 
Methods: This prospective randomized study analyzed 80 patients that 
underwent ﬂexible bronchoscopy for lung cancer diagnostic. Patients 
were randomly assigned to four groups of 20 patients each according 
to the anesthetic combination used: 200 mg topical lidocaine (LID 
group); 200 mg topical lidocaine and 2 mg/kg propofol (PPF group); 
200 mg topical lidocaine and 20 mcg/kg alfentanil (ALF group); or 200 
mg topical lidocaine and 0.05 mg/kg midazolam (MID group). Scores 
were assigned to patients according to the different variables observed 
during the bronchoscopic procedure; the lower the score, the lower the 
complication index. 
Results: Results of the composite score (mean and standard devia-
tion) for the evaluation of the variables observed during ﬂexible 
bronchoscopy were 4.6„b3.9 for the PPF group, 7.9„b6.6 for the ALF 
group, 10.0„b4.5 for the LID group, and 11.3„b5.8 for the MID group 
(p=0.001).
Conclusions: Results showed that the combination of propofol and 
topical lidocaine was a superior anesthetic method for ﬂexible bron-
choscopy than lidocaine alone or in association with midazolam or 
alfentanil.
Clinical Implications: The choice of an effective and low morbidity 
anesthetic method is basic for the success of a diagnostic ﬂexible bron-
choscopy. This study it demonstrated the superiority of the association 
of propofol and topic lidocaine in the anesthesia for ﬂexible bronchos-
copy in lung cancer patients.
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Background: Adenocarcinoma of the lung is more frequent in females 
than in males and the association with smoking is less pronounced than 
for the other histological subtypes of lung cancer. Thus other factors 
than smoking may be involved in the carcinogenesis of lung cancer. 
Estrogen induction of cellproliferation has been found in for example 
breast adenocarcinoma and since estrogen receptors (ER) have been 
demonstrated in lung tumours, a similar role of estrogens in the devel-
opment of lung cancer has been suggested. 
Whereas ERalfa plays a key role in adenocarcinomas of the breast, sev-
eral studies indicate a more predominant role of ERbeta in lung cancer. 
We examined the expression of ERalfa, ERbeta, and Progesterone in a 
well deﬁned Danish cohort of patients with NSCLC with more than 15 
years of follow up, and related the results to gender and survival. 
Methods: Parafﬁn embedded, histological material was collected from 
104 patients (71 men and 33 women), operated in the period 1989-1992 
for NSCLC (56 squamous cell carcinomas, 40 adenocarcinomas and 8 
large cell carcinomas). Sixtythree patients were in stage I, 14 patients 
in stage II, 24 patients in stage IIIA, and 3 patients in stage IIIB.
ERalfa (clone 1D5, DAKO), ERbeta (clone PPG5/10, DAKO) and Pro-
gesterone (clone PgR 636, DAKO) were immunohistochemically ana-
lyzed. Staining frequency and intensity was scored semiquantitatively. 
A tumour was deﬁned as positive when more than 10% of the tumour 
cells were positive with at least a weak nuclear staining. Kaplan-Meier 
survival curves were generated to evaluate the signiﬁcance of ERalfa, 
ERbeta and Progesterone expression for the prognosis. 
Results: ERbeta positivity was demonstrated in 69% (72 of 104) of the 
tumours. There was no statistically signiﬁcant correlation between ER-
beta positivity and age, sex, stage, or histology. After adjusting for sex, 
age, stage at diagnosis and histology there was no difference in survival 
between subjects with ERbeta-positive and ERbeta-negative tumours. 
Analysis was repeated after stratifying by sex. Women with ERbeta-
negative tumours had a non-signiﬁcant (p=0.26) decrease in mortality 
compared with women with ERbeta positive tumours. In contrast, men 
with ERbeta positive tumours had a reduced mortality (p=0.03) com-
pared to men with ERbeta negative tumours (see Figure). 
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Using multivariate regression analysis the interaction between gender 
and positive ERbeta staining was the only signiﬁcant prognostic factor. 
There was no correlation between the ERalfa immunohistochemical 
reaction and any of the clinical variables, including survival. None of 
the 104 patients had tumours positive for Progesterone. 
Conclusion: The presence of ERbeta in a tumour seems to be a posi-
tive prognostic factor for men with non-small cell lung cancer. The 
ﬁndings are in agreement with recent ﬁndings (1) and suggests the area 
of estrogen and lung cancer to be investigated further.
1.  Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J et al. Nuclear 
estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin.
Cancer Res. 2005;11:7280-7.
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Background: Recent molecular studies have provided increased under-
standing of the biology of non-small cell lung cancer (NSCLC) and have 
identiﬁed molecular abnormalities responsible for the modulation of 
tumor growth and the prognosis. Nevertheless, the essential genetic fea-
tures, along with factors for prognosis, have yet to be fully understood. 
This study was undertaken to investigate such immunophenotypes with 
regard to cell cycle regulation and proliferation, apoptosis, and angio-
genesis, and their signiﬁcance to patient outcome.
Design: Two hundred and nineteen NSCLC samples were assembled 
on tissue microarrays, and examined immunohistochemically using 
antibodies against p16, p21, p27, cyclin B1, cyclin E, Ki-67, caspase-
3, survivin, bcl-2, VEGF and endostatin. Clinical information was 
obtained through the computerized retrospective database from the 
tumor registry.
Results: One hundred and sixty-eight patients (76.7%) were male and 
the mean age was 65.8 years (SD 9.9; median 67; age range 19-89). 
Despite previously described prognostic relevance of some of the 11 
investigated molecules, many were found not to be directly associated 
with recurrence or survival. However, p16 and bcl-2 had an impact on 
5-year survival. There was a trend for p16 immunoreactivity to be relat-
ed with a good prognosis (57% vs. 42% in 5-year survival) (p=0.071). 
Bcl-2 expression in tumor tissue strongly correlated with a better out-
come (65% vs. 45% in 5-year survival rate) (p=0.029), and the hazard 
ratio of death for bcl-2 positive patients was 0.42 times of that for bcl-2 
negative patients (p=0.047). A multivariate analysis with Cox propor-
tional hazards model conﬁrmed that the lymph node status (p=0.043) 
and stage (p=0.003) were other independent prognostic factors. 
Conclusion: The present study demonstrates that NSCLCs have het-
erogeneous expression of cell cycle regulatory proteins, apoptotic fac-
tors and angiogenic factors. The expressions of p16 and bcl-2 correlate 
with better survival, suggesting that both proteins provide prognostic 
information independent of TNM stage in NSCLCs.
PD1-3-5 Pathology and Bronchoscopy, Mon, 16:00 - 17:30
Evaluation of resected tumors that were not diagnosed 
histologically but were suspected of lung cancer preoperatively 
Sawada, Shigeki Yamashita, Motohiro Komori, Eisaku Nogami, 
Naoyuki Oze, Isao Segawa, Yoshihiko Shinkai, Tetsu 
Shikoku Cancer Center, Matsuyama, Japan
Background: Lung cancer is the most common cause of cancer death 
around the world. Diagnosis is critical to decide treatment. However, 
due to technical difﬁculties, it is often difﬁcult to obtain histological 
diagnosis with a clinical workup including bronchoﬁber and CT-guided 
needle biopsy. In such cases, patients undergo resection without a 
histological diagnosis. In some patients, postoperative histological 
examination demonstrates benign diseases. In this study, we identiﬁed 
patients without preoperative histological diagnosis who underwent 
resection and evaluated their histology. We also discuss the inﬂuence of 
CT screening on this issue.
Methods: A retrospective study was performed by reviewing medical 
records between 1997 and 2005. There are 1039 patients who under-
went surgical resection under a diagnosis of lung cancer or suspected 
lung cancer. In 523 patients, histological diagnosis of lung cancer was 
obtained with a routine workup preoperatively. In 516 patients, the 
histological diagnosis was not conﬁrmed preoperatively. We reviewed 
the reasons for the lack of histological diagnosis and classiﬁed patients 
into three groups, 1)bronchoﬁber and/or CT-guided needle biopsy were 
performed but histological diagnosis could not be established; 2)Tumor 
was small and bronchoﬁber and/or CT-guided needle biopsy was not 
performed; and 3)CT imaging indicated highly suspected lung cancer 
and bronchoﬁber and/or CT-guided needle biopsy was skipped. We also 
reviewed postoperative histology. 
Results: Of the 1039 patients who underwent surgical resection under 
a diagnosis of lung cancer or suspected lung cancer between 1997 
and 2005, preoperative histological diagnosis was not obtained in 516 
patients (46.2%). In our area, CT screening was initiated in 1998. The 
proportion of undiagnosed cases was approximately 30 % before 1998 
and increased to approximately 55 % after 1999. The increase seemed 
to be related to the initiation of CT screening. In 108 patients, broncho-
ﬁber and /or CT-guided needle biopsy was performed but histological 
diagnosis could not be obtained. In 270 patients, the tumor was consid-
ered too small for bronchoﬁber or CT-guided needle biopsy and these 
modalities were not performed. In 138 patients, CT imaging highly 
suspected lung cancer and resection was performed without histologi-
cal conﬁrmation. Postoperative histological examination demonstrated 
primary lung cancer in 422 patients (81.8%), metastatic lung cancer in 
25 (4.8%) and benign disease in 69 (13.4%). 
Comment: We reviewed 516 patients who underwent resection 
without histological diagnosis. After the initiation of CT screening, the 
proportion of cases that were not diagnosed preoperatively increased 
to approximately 55 %. Histological examination demonstrated benign 
diseases in 69(13.4%). Recently small lung tumor has been detected 
more frequently, especially since the initiation of CT screening. Some 
patients undergo resection without histological conﬁrmation. Surgical 
indications for undiagnosed cases should be considered carefully. 
